1. AB0568 BASELINE EUROPEAN PATIENT DEMOGRAPHICS AND DISEASE CHARACTERISTICS IN A PHASE 3 STUDY OF SAFETY AND EFFICACY OF LENABASUM, A CB2 AGONIST, IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS. (2nd June 2020) Authors: Denton, C.; Bloom, B.; Dgetluck, N.; White, B.; Spiera, R. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0470 A phase 2 study of safety and efficacy of lenabasum (JBT-101), a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis. (12th June 2018) Authors: Werth, V.P.; Hejazi, E.; Pena, S.M.; Haber, J.S.; Okawa, J.; Feng, R.; Gabre, K.; Concha, J.S.; Cornwall, C.; Dgetluck, N.; Constantine, S.; White, B. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0006 Safety and efficacy of lenabasum (JBT-101) in diffuse cutaneous systemic sclerosis subjects treated for one year in an open-label extension of trial jbt101-ssc-001. (12th June 2018) Authors: Spiera, R.; Hummers, L.; Chung, L.; Frech, T.; Domsic, R.; Hsu, V.; Furst, D.E.; Gordon, J.; Mayes, M.; Simms, R.; Lee, E.; Dgetluck, N.; Constantine, S.; White, B. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0512 Safety and efficacy of lenabasum in refractory skin-predominant dermatomyositis subjects treated in an open label extension of trial jbt101-dm-001. (12th June 2018) Authors: Werth, V.P.; Patel, B.; Concha, J.S.; Okawa, J.; Pearson, D.; Hejazi, E.; Feng, R.; Cornwall, C.; Dgetluck, N.; Constantine, S.; Aggarwal, A.; White, B. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗